Reumatologia
Estudo randomizado fase 2 | Segurança, tolerabilidade e eficácia da pirfenidona em pacientes com doença pulmonar intersticial associada a artrite reumatoide.
8 Set, 2022 | 13:41h
Comentário no Twitter
NEW Research—Pirfenidone slowed the rate of decline of FVC over time in patients with RA-ILD*
Being presented at #ERSCongress, ALERT 3 session, Sept 5 from 13:15 BST
From Joshua Solomon & colleagues https://t.co/Nu8wECECdD
*(please check study limitations) pic.twitter.com/IuRxLDZGd9
— The Lancet Respiratory Medicine (@LancetRespirMed) September 5, 2022
Estudo randomizado | Olokizumabe vs. placebo ou adalimumabe na artrite reumatoide.
29 Ago, 2022 | 17:13hOlokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis – MedPage Today (necessário cadastro gratuito)
Estudo observacional sugere que a hidroxicloroquina está associada com risco aumentado de eventos cardiovasculares em comparação ao metotrexato em pacientes com insuficiência cardíaca.
29 Ago, 2022 | 17:03hCardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis – Journal of the American College of Cardiology (link para o resumo – $ para o texto completo)
Editorial: Hydroxychloroquine: Heart-Throb No More? – Journal of the American College of Cardiology
Comentário: Caution needed with hydroxychloroquine use in older RA patients with heart failure – medwire News
Revisão sistemática | Monitoramento farmacoterápico de biofarmacêuticos na doença reumática inflamatória e musculoesquelética.
29 Ago, 2022 | 17:01hConteúdo relacionado: EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.
Tratamento da osteoartrite da mão: de uma diretriz médica norte-americana baseada em evidências para uma abordagem europeia centrada no paciente.
29 Ago, 2022 | 16:32hConteúdos relacionados:
Erosive hand osteoarthritis: latest findings and outlook – Nature Reviews Rheumatology
ACR Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee
Research: Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis
Podcast | Miosite e miopatia.
29 Ago, 2022 | 16:29h#348 Myositis and Myopathy, LIVE! – The Curbsiders
Revisão sistemática | Não há evidências suficientes para recomendar tênis de corrida para prevenir lesões de membro inferior relacionadas a corrida em adultos.
29 Ago, 2022 | 13:50hRunning shoes for preventing lower limb running injuries in adults – Cochrane Library
Resumo: Running shoes for preventing lower-limb running injuries in adults – Cochrane Library
Comentário no Twitter
👟Running shoes have been proposed as one means of reducing injury risk….but are they effective? @CochraneBJMT authors looked at 12 trials that lasted 6-26 wks with 11,240 people. https://t.co/09bt9SzEkh pic.twitter.com/qi5qk7W1I1
— The Cochrane Library (@CochraneLibrary) August 22, 2022
Diretriz de consenso | Manejo pré-operatório de medicações para doenças reumatológicas e relacionadas ao HIV.
23 Ago, 2022 | 17:17hConteúdos relacionados:
Preoperative Management of Medications for Neurologic Diseases – Mayo Clinic Proceedings
Preoperative Management of Surgical Patients Using Dietary Supplements – Mayo Clinic Proceedings
Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
Preoperative Cardiac Risk Assessment – Mayo Clinic Proceedings
Preoperative Evaluation Before Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Cardiac Risk Reduction in Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
Estudo randomizado | Reconstrução cirúrgica é superior à reabilitação para pacientes com lesão de ligamento cruzado anterior não aguda com sintomas persistentes de instabilidade.
23 Ago, 2022 | 17:12h
Comentário no Twitter
Surgical reconstruction of non-acute ACL injury with persistent symptoms of instability was superior in comparison with rehabilitation at 18 months (KOOS4 mean difference 7.9 (95% CI 2.5–13.2)): https://t.co/y2taBzHolU pic.twitter.com/n0qW3B6cMv
— Søren T. Skou (@STSkou) August 19, 2022
Sob licença de Creative Commons Attribution (CC BY 4.0)
Revisão | Lúpus eritematoso sistêmico e doença cardiovascular.
23 Ago, 2022 | 16:52hSystemic lupus erythematosus and cardiovascular disease – Journal of Internal Medicine